These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12821749)

  • 1. Neurotoxicity following addition of intravenous valproate to lamotrigine therapy.
    Burneo JG; Limdi N; Kuzniecky RI; Knowlton RC; Mendez M; Lawn N; Faught E; Welty TE; Prasad A
    Neurology; 2003 Jun; 60(12):1991-2. PubMed ID: 12821749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disabling tremor after lamotrigine with sodium valproate.
    Reutens DC; Duncan JS; Patsalos PN
    Lancet; 1993 Jul; 342(8864):185-6. PubMed ID: 8101290
    [No Abstract]   [Full Text] [Related]  

  • 4. Adding valproate to lamotrigine: a study of their pharmacokinetic interaction.
    Kanner AM; Frey M
    Neurology; 2000 Aug; 55(4):588-91. PubMed ID: 10953201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium valproate acutely inhibits lamotrigine metabolism.
    Yuen AW; Land G; Weatherley BC; Peck AW
    Br J Clin Pharmacol; 1992 May; 33(5):511-3. PubMed ID: 1524964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
    Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
    Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine-induced rash--worth a rechallenge.
    P-Codrea Tigaran S; Sidenius P; Dam M
    Acta Neurol Scand; 2005 Mar; 111(3):191-4. PubMed ID: 15736314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to replace lamotrigine with valproate.
    Steinhoff BJ
    Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus anticoagulant induced by the combination of valproate and lamotrigine.
    Echaniz-Laguna A; Thiriaux A; Ruolt-Olivesi I; Marescaux C; Hirsch E
    Epilepsia; 1999 Nov; 40(11):1661-3. PubMed ID: 10565597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoclonic status epilepticus following high-dosage lamotrigine therapy.
    Guerrini R; Belmonte A; Parmeggiani L; Perucca E
    Brain Dev; 1999 Sep; 21(6):420-4. PubMed ID: 10487478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non convulsive status epilepticus after replacement of valproate with lamotrigine.
    Trinka E; Dilitz E; Unterberger I; Luef G; Deisenhammer F; Niedermüller U; Thaler C; Bauer G
    J Neurol; 2002 Oct; 249(10):1417-22. PubMed ID: 12382160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers.
    Aldenkamp AP; Arends J; Bootsma HP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Vocht J
    Epilepsia; 2002 Jan; 43(1):19-26. PubMed ID: 11879382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine and valproate pharmacokinetics interactions in epileptic patients.
    Lalic M; Cvejic J; Popovic J; Bozic K; Golocorbin-Kon S; Al-Salami H; Mikov M
    Eur J Drug Metab Pharmacokinet; 2009; 34(2):93-9. PubMed ID: 19645218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
    Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
    Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of reversal of valproate-mediated inhibition of lamotrigine.
    Leary E; Sheth RD; Gidal BE
    Seizure; 2018 Apr; 57():76-79. PubMed ID: 29574285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate.
    Hashim N; Bandara D; Tan E; Ilchyshyn A
    Acta Derm Venereol; 2004; 84(1):90-1. PubMed ID: 15040495
    [No Abstract]   [Full Text] [Related]  

  • 19. Vulnerability of an epileptic case to psychosis: sodium valproate with lamotrigine, forced normalization, postictal psychosis or all?
    Turan AB; Seferoglu M; Taskapilioglu O; Bora I
    Neurol Sci; 2012 Oct; 33(5):1161-3. PubMed ID: 22131039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
    Gulcebi MI; Ozkaynakcı A; Goren MZ; Aker RG; Ozkara C; Onat FY
    Epilepsy Res; 2011 Jun; 95(1-2):1-8. PubMed ID: 21601426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.